Stockscreener 앱 받기
17.95
0.06%
0.010
전일 마감가:
$17.94
열려 있는:
$17.87
하루 거래량:
11.32M
Relative Volume:
1.62
시가총액:
$9.22B
수익:
$10.89B
순이익/손실:
$-241.00M
주가수익비율:
-67.58
EPS:
-0.2656
순현금흐름:
$340.00M
1주 성능:
-19.94%
1개월 성능:
-24.77%
6개월 성능:
-41.01%
1년 성능:
-50.28%
1일 변동 폭
$17.46
$18.08
1주일 범위
$17.46
$19.80
52주 변동 폭
$17.46
$37.74
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
BAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.95 | 9.21B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
548.55 | 191.01B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
176.39 | 51.32B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.34 | 36.68B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
245.22 | 35.97B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
283.54 | 20.64B | 2.96B | 487.70M | 344.00M | 6.6758 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Why Baxter International Inc. stock is listed among top recommendations2025 AllTime Highs & Accurate Buy Signal Notifications - fcp.pa.gov.br
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Will Baxter International Inc. (BTL) stock justify high valuationWeekly Trade Report & Low Drawdown Investment Strategies - fcp.pa.gov.br
Will Baxter International Inc. stock outperform tech sector in 20252025 Risk Factors & AI Powered Trade Plan Recommendations - fcp.pa.gov.br
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
How Baxter International Inc. stock performs in weak economyMarket Risk Summary & Reliable Entry Point Alerts - fcp.pa.gov.br
Baxter International (NYSE:BAX) Sets New 52-Week LowHere's Why - MarketBeat
Day 6 of Loss Streak for Baxter International Stock with -23% Return (vs. -37% YTD) [11/4/2025] - Trefis
Bank of New York Mellon Corp Has $399.36 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
How high can Baxter International Inc. stock go2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Why Baxter International (BAX) Is Down 21.5% After Novum Infusion Pump Disruptions and Lawsuits - simplywall.st
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit - PR Newswire
2025-11-04 | Baxter International, Inc. (BAX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 15, 2025 Deadline | NYSE:BAX | Press Release - Stockhouse
Bragar Eagel & Squire, P.C. Reminds Investors of Baxter, - GlobeNewswire
Baxter International, Inc. (BAX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - The Malaysian Reserve
December 15, 2025 Deadline: Join Class Action Lawsuit Against Baxter International, Inc. (BAX)Contact Levi & Korsinsky - The Globe and Mail
Lacklustre Performance Is Driving Baxter International Inc.'s (NYSE:BAX) Low P/S - 富途牛牛
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - GlobeNewswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Don't Write Off Baxter Just Yet (NYSE:BAX) - Seeking Alpha
Can Baxter International Inc. stock surprise with earnings upsideJuly 2025 PostEarnings & Weekly Breakout Watchlists - fcp.pa.gov.br
Day 5 of Loss Streak for Baxter International Stock with -21% Return (vs. -36% YTD) [11/3/2025] - Trefis
Non-PVC IV Bags Market Poised for Rapid Explosive Growth| Baxter - openPR.com
How Attractive Is Baxter After a 21% Weekly Drop and Strategic Divestitures in 2025? - simplywall.st
Class Action Filed Against Baxter International, Inc. (BAX) - GlobeNewswire
Deadline Alert: Baxter International, Inc. (BAX) - GlobeNewswire
Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Morningstar
Baxter International, Inc. Securities Fraud Class Action Lawsuit - GuruFocus
Baxter International, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before December 15, 2025 to Discuss Your RightsBAX - Morningstar
United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceuticals, Astellas Pharma, Baxter, Pfizer, Dr. Reddy's LaboratoriesResearchAndMarkets.com - FinancialContent
Investor Alert: Deadline Approaching to Join Baxter International, Inc. (BAX) Class ActionContact Levi & Korsinsky - The Globe and Mail
What Developments Are Shaping the Narrative for Baxter International’s Future? - Yahoo Finance
Baxter International (BAX) Stock Plunges on Q3 2025 Revenue Miss and Guidance CutNews and Statistics - IndexBox
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - Lelezard
2025-11-03 | December 15, 2025 Deadline Approaching: Join Class Action Against Baxter International, Inc. (BAX)Contact Levi & Korsinsky | NYSE:BAX | Press Release - Stockhouse
Is Wall Street Bullish or Bearish on Baxter International Stock? - Barchart.com
BAXTER INTERNATIONAL INC. (NYSE: BAX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Baxter ... - Bluefield Daily Telegraph
BAXTER INTERNATIONAL INC. (NYSE: BAX) SHAREHOLDER ALERT - GlobeNewswire
How Baxter International Inc. stock performs during market turbulenceWeekly Trend Report & AI Driven Stock Price Forecasts - newser.com
Why Baxter International Inc. stock is a must watch ticker2025 Performance Recap & Advanced Technical Analysis Signals - newser.com
Key facts: Baxter International halts Novum LVP shipments; class action filed - TradingView
Research Alert: CFRA Keeps Sell Rating On Shares Of Baxter International Inc. - 富途牛牛
Will Baxter International Inc. stock benefit from infrastructure billMarket Volume Report & Smart Money Movement Alerts - newser.com
Baxter International (NYSE:BAX) Price Target Cut to $19.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Newsfile
Cooke & Bieler LP Increases Holdings in Baxter International Inc. $BAX - MarketBeat
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
1.31%
자본화:
|
볼륨(24시간):